Приказ основних података о документу

dc.creatorPavlović, Bojan
dc.creatorBožić, Dragana
dc.creatorMilovanović, Jovica
dc.creatorJotić, Ana
dc.creatorĐukić, Vojko
dc.creatorĐukić, Slobodanka
dc.creatorKonstantinović, Neda
dc.creatorCirković, Ivana
dc.date.accessioned2019-09-02T11:54:43Z
dc.date.available2019-09-02T11:54:43Z
dc.date.issued2016
dc.identifier.issn1217-8950
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2695
dc.description.abstractObjectives: Biofilms are associated with persistent infections and resistant to conventional therapeutic strategies. The aim of this study was to investigate the quantity of biofilm produced on silicone intranasal splints. Methods: Quantity of biofilm formation on silicone splints (SS) was tested on 15 strains of Staphylococcus aureus and Moraxella catarrhalis, respectively. Antimicrobial susceptibility testing was performed in accordance with European Committee on Antimicrobial Susceptibility Testing recommendations. Results: All tested strains formed different amounts of biofilm on SS: 66.7% S. aureus and 93.3% M. catarrhalis were weak biofilm producers and 33.3% S. aureus and 6.7% M. catarrhalis were moderate biofilm producers. S. aureus formed significantly higher quantity of biofilm compared with M. catarrhalis (p lt 0.05). Multidrug resistant S. aureus produced significantly higher amount of biofilm compared with non-multidrug resistant strains (p lt 0.05). Conclusion: Quantity of biofilm on SS is highly dependent on bacterial species and their resistance patterns. Future studies are needed to ascertain another therapeutic option for prophylaxis prior to SS placement.en
dc.publisherAkademiai Kiado Rt, Budapest
dc.rightsopenAccess
dc.sourceActa Microbiologica et Immunologica Hungarica
dc.titleQuantification of biofilm formation on silicone intranasal splints: An in vitro studyen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЂукић, Војко; Константиновић, Неда; Божић, Драгана; Павловић, Бојан; Миловановић, Јовица; Јотић, Aна; Ђукић, Слободанка; Цирковић, Ивана;
dc.citation.volume63
dc.citation.issue3
dc.citation.spage301
dc.citation.epage311
dc.citation.other63(3): 301-311
dc.citation.rankM23
dc.identifier.wos000384749200004
dc.identifier.doi10.1556/030.63.2016.006
dc.identifier.pmid27682847
dc.identifier.scopus2-s2.0-84990181877
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/1347/2693.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу